Urokinase type plasminogen activator receptor expression in colorectal neoplasms.
about
HER2 and uPAR cooperativity contribute to metastatic phenotype of HER2-positive breast cancerGenome-wide analysis in human colorectal cancer cells reveals ischemia-mediated expression of motility genes via DNA hypomethylationEnhanced activity of meprin-α, a pro-migratory and pro-angiogenic protease, in colorectal cancer.Epithelial and stromal cell urokinase plasminogen activator receptor expression differentially correlates with survival in rectal cancer stages B and C patients.Docosahexaenoic Acid Inhibits Tumor Promoter-Induced Urokinase-Type Plasminogen Activator Receptor by Suppressing PKCδ- and MAPKs-Mediated Pathways in ECV304 Human Endothelial Cells.High concentration of urokinase-type plasminogen activator receptor in the serum of women with primary breast cancer.Modulators of the urokinase-type plasminogen activation system for cancer.Development of novel therapeutics targeting the urokinase plasminogen activator receptor (uPAR) and their translation toward the clinic.Urokinase-type plasminogen activator and its receptor in colorectal cancer: independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets.Intact and cleaved plasma soluble urokinase receptor in patients with metastatic colorectal cancer treated with oxaliplatin with or without cetuximab.Bacterial endotoxin enhances colorectal cancer cell adhesion and invasion through TLR-4 and NF-kappaB-dependent activation of the urokinase plasminogen activator system.Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression.Identification of an histone H3 acetylated/K4-methylated-bound intragenic enhancer regulatory for urokinase receptor expression
P2860
Q28085413-28F29CA3-E157-47E9-B1CC-9D020A1A3CE3Q28391482-A1000F32-E65E-4356-9D04-CD87C0B0057AQ34077651-F7F86BD7-26B4-4808-9C20-CD70D3F12536Q35097486-2C19303D-92B5-4A3C-B542-71038DE94524Q36139904-DE33D025-BD4B-4386-AF12-D3F09394899BQ37601854-5ACFDFEA-700C-440B-BA5B-CB396FF0067AQ37733590-2A05CAFA-2757-455C-BAD1-4EACE6AC50A2Q37895294-AB180B48-7CB1-4005-B0A3-8FBBEF3710E8Q38308022-BA443007-57C4-4913-AB3D-E40F15FA025AQ41460793-485D9750-4AEB-45C5-8DBF-B7F59A922E5AQ41465764-CA960B0B-AFC6-45BC-8D66-76D793B648B3Q42937214-0711B983-6502-443F-93DD-793EF3E2E502Q58482772-A168EFB0-75BC-44BA-8BE9-775733EA76F6
P2860
Urokinase type plasminogen activator receptor expression in colorectal neoplasms.
description
1998 nî lūn-bûn
@nan
1998 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Urokinase type plasminogen activator receptor expression in colorectal neoplasms.
@ast
Urokinase type plasminogen activator receptor expression in colorectal neoplasms.
@en
type
label
Urokinase type plasminogen activator receptor expression in colorectal neoplasms.
@ast
Urokinase type plasminogen activator receptor expression in colorectal neoplasms.
@en
prefLabel
Urokinase type plasminogen activator receptor expression in colorectal neoplasms.
@ast
Urokinase type plasminogen activator receptor expression in colorectal neoplasms.
@en
P2093
P2860
P356
P1433
P1476
Urokinase type plasminogen activator receptor expression in colorectal neoplasms.
@en
P2093
Kawasaki K
Nakamura T
P2860
P304
P356
10.1136/GUT.43.6.798
P407
P577
1998-12-01T00:00:00Z